135 related articles for article (PubMed ID: 25490144)
21. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling.
Devi GR; Yang DH; Rosenfeld RG; Oh Y
Endocrinology; 2000 Nov; 141(11):4171-9. PubMed ID: 11089550
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor (IGF) II induced changes in expression of IGF binding proteins in lymphoid tissues of hIGF-II transgenic mice.
Smink JJ; Koster JG; Hendriks-Stegeman BI; Van Buul-Offers SC
Endocrinology; 1999 Dec; 140(12):5876-82. PubMed ID: 10579353
[TBL] [Abstract][Full Text] [Related]
23. Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance.
Crossey PA; Jones JS; Miell JP
Diabetes; 2000 Mar; 49(3):457-65. PubMed ID: 10868969
[TBL] [Abstract][Full Text] [Related]
24. Growth Hormone Receptor Antagonist Transgenic Mice Have Increased Subcutaneous Adipose Tissue Mass, Altered Glucose Homeostasis and No Change in White Adipose Tissue Cellular Senescence.
Comisford R; Lubbers ER; Householder LA; Suer O; Tchkonia T; Kirkland JL; List EO; Kopchick JJ; Berryman DE
Gerontology; 2016; 62(2):163-72. PubMed ID: 26372907
[TBL] [Abstract][Full Text] [Related]
25. Heparin-binding EGF-like growth factor (HB-EGF) overexpression in transgenic mice downregulates insulin-like growth factor binding protein (IGFBP)-3 and -4 mRNA.
Provenzano AP; Besner GE; James PF; Harding PA
Growth Factors; 2005 Mar; 23(1):19-31. PubMed ID: 16019424
[TBL] [Abstract][Full Text] [Related]
26. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
Khorram O; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
[TBL] [Abstract][Full Text] [Related]
27. The RGD sequence present in IGFBP-2 is required for reduced glucose clearance after oral glucose administration in female transgenic mice.
Reyer A; Schindler N; Ohde D; Walz C; Kunze M; Tuchscherer A; Wirthgen E; Brenmoehl J; Hoeflich A
Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E409-17. PubMed ID: 26105006
[TBL] [Abstract][Full Text] [Related]
28. Perturbations in bone formation and resorption in insulin-like growth factor binding protein-3 transgenic mice.
Silha JV; Mishra S; Rosen CJ; Beamer WG; Turner RT; Powell DR; Murphy LJ
J Bone Miner Res; 2003 Oct; 18(10):1834-41. PubMed ID: 14584894
[TBL] [Abstract][Full Text] [Related]
29. Effects of milk replacer composition on selected blood metabolites and hormones in preweaned Holstein heifers.
Daniels KM; Hill SR; Knowlton KF; James RE; McGilliard ML; Akers RM
J Dairy Sci; 2008 Jul; 91(7):2628-40. PubMed ID: 18565922
[TBL] [Abstract][Full Text] [Related]
30. The effect of oral glucose on serum free insulin-like growth factor-I and -II in health adults.
Frystyk J; Grøfte T; Skjaerbaek C; Orskov H
J Clin Endocrinol Metab; 1997 Sep; 82(9):3124-7. PubMed ID: 9284756
[TBL] [Abstract][Full Text] [Related]
31. Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls.
Rutanen EM; Stenman S; Blum W; Kärkkäinen T; Lehtovirta P; Stenman UH
J Clin Endocrinol Metab; 1993 Jul; 77(1):199-204. PubMed ID: 7686914
[TBL] [Abstract][Full Text] [Related]
32. Growth selection in mice reveals conserved and redundant expression patterns of the insulin-like growth factor system.
Hoeflich A; Bünger L; Nedbal S; Renne U; Elmlinger MW; Blum WF; Bruley C; Kolb HJ; Wolf E
Gen Comp Endocrinol; 2004 Apr; 136(2):248-59. PubMed ID: 15028529
[TBL] [Abstract][Full Text] [Related]
33. No decrease in free IGF-I with increasing insulin in obesity-related insulin resistance.
Ricart W; Fernández-Real JM
Obes Res; 2001 Oct; 9(10):631-6. PubMed ID: 11595780
[TBL] [Abstract][Full Text] [Related]
34. Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance.
Rao MN; Mulligan K; Tai V; Wen MJ; Dyachenko A; Weinberg M; Li X; Lang T; Grunfeld C; Schwarz JM; Schambelan M
J Clin Endocrinol Metab; 2010 Sep; 95(9):4361-6. PubMed ID: 20610601
[TBL] [Abstract][Full Text] [Related]
35. Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2.
Hoeflich A; Nedbal S; Blum WF; Erhard M; Lahm H; Brem G; Kolb HJ; Wanke R; Wolf E
Endocrinology; 2001 May; 142(5):1889-98. PubMed ID: 11316754
[TBL] [Abstract][Full Text] [Related]
36. Hyperglycemia and impaired glucose tolerance in IGF binding protein-1 transgenic mice.
Rajkumar K; Dheen ST; Murphy LJ
Am J Physiol; 1996 Apr; 270(4 Pt 1):E565-71. PubMed ID: 8928760
[TBL] [Abstract][Full Text] [Related]
37. Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: endocrine changes and effects on body and organ growth.
Wolf E; Kramer R; Blum WF; Föll J; Brem G
Endocrinology; 1994 Nov; 135(5):1877-86. PubMed ID: 7525257
[TBL] [Abstract][Full Text] [Related]
38. Free insulin-like growth factor I (IGF-I) in healthy subjects: relationship with IGF-binding proteins and insulin sensitivity.
Nyomba BL; Berard L; Murphy LJ
J Clin Endocrinol Metab; 1997 Jul; 82(7):2177-81. PubMed ID: 9215291
[TBL] [Abstract][Full Text] [Related]
39. Human C-reactive protein exacerbates metabolic disorders in association with adipose tissue remodelling.
Kaneko H; Anzai T; Nagai T; Anzai A; Takahashi T; Mano Y; Morimoto K; Maekawa Y; Itoh H; Yoshikawa T; Ogawa S; Fukuda K
Cardiovasc Res; 2011 Aug; 91(3):546-55. PubMed ID: 21447704
[TBL] [Abstract][Full Text] [Related]
40. Chondrocytes from osteoarthritic cartilage have increased expression of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 (IGFBP-3) and -5, but not IGF-II or IGFBP-4.
Olney RC; Tsuchiya K; Wilson DM; Mohtai M; Maloney WJ; Schurman DJ; Smith RL
J Clin Endocrinol Metab; 1996 Mar; 81(3):1096-103. PubMed ID: 8772582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
